Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.14B | 4.96B | 5.24B | 5.66B | 5.53B |
| Total Depreciation and Amortization | 686.00M | 710.00M | 724.00M | 743.00M | 804.00M |
| Total Amortization of Deferred Charges | 803.00M | 803.00M | 803.00M | 803.00M | 734.00M |
| Total Other Non-Cash Items | -1.29B | -438.00M | -333.00M | 359.00M | 612.00M |
| Change in Net Operating Assets | 2.26B | 1.43B | 1.17B | -3.28B | -2.77B |
| Cash from Operations | 7.60B | 7.46B | 7.61B | 4.29B | 4.91B |
| Capital Expenditure | -1.08B | -1.18B | -1.16B | -1.12B | -1.15B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 35.00M | 39.00M | 89.00M | 88.00M | -3.63B |
| Divestitures | -- | -- | -- | -- | -36.00M |
| Other Investing Activities | -1.96B | -1.11B | -2.02B | -316.00M | 1.37B |
| Cash from Investing | -3.01B | -2.24B | -3.09B | -1.34B | -3.45B |
| Total Debt Issued | 2.86B | 6.06B | 6.40B | 6.19B | 9.67B |
| Total Debt Repaid | -2.27B | -5.52B | -4.55B | -3.87B | -4.78B |
| Issuance of Common Stock | 146.00M | 121.00M | 95.00M | 81.00M | 39.00M |
| Repurchase of Common Stock | -2.20B | -2.73B | -2.79B | -2.64B | -3.98B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.50B | -1.51B | -1.52B | -1.53B | -1.53B |
| Other Financing Activities | 26.00M | 42.00M | 33.00M | 22.00M | 3.00M |
| Cash from Financing | -2.94B | -3.53B | -2.34B | -1.74B | -566.00M |
| Foreign Exchange rate Adjustments | -20.00M | -19.00M | -15.00M | -5.00M | -7.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -46.00M |
| Net Change in Cash | 1.64B | 1.67B | 2.16B | 1.20B | 847.00M |